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Vitamin K-dependent proteins contain a propeptide that is
required for recognition by the enzyme γ-glutamylcarboxylase.
Substrates used in itro for carboxylation studies lacking a
prosequence are characterized by K
m
values in the millimolar
range, whereas the K
m
for peptides containing a prosequence is
three or four orders of magnitude smaller. Here we report
that descarboxy-osteocalcin is an exception in this respect. With
descarboxy-osteocalcin in purified propeptide-free recombinant
carboxylase, the K
m
was 1.8 µM. Furthermore, osteocalcin was




Osteocalcin (OC), also called bone γ-carboxyglutamate (Gla)-
protein (BGP) [1], is the most abundant non-collagenous protein
in bone [2]. The mature protein consists of 49 amino acid residues
and has a molecular mass of 5700 Da [3,4]. During its bio-
synthesis, OC undergoes a series of post-translational modifi-
cations including the conversion of three glutamate residues into
Gla residues. In this process vitamin K serves as a coenzyme for
γ-glutamylcarboxylase, an integral membrane protein of 94 kDa
residing in the rough endoplasmic reticulum of various mam-
malian cells [5,6]. Natural substrates for γ-glutamylcarboxylase
include precursors of proteins involved in blood coagulation
(prothrombin, factor VII, factor IX, factor X, protein C, protein
S and protein Z) [7], those involved in tissue mineralization [OC
and matrix Gla-protein (MGP)] [8,9], and the growth-arrest-
specific gene 6 protein, Gas6 [10].
Other than MGP, which has an internal recognition site for
carboxylase, all Gla-proteins characterized so far are synthesized
as preproproteins [11]. The presequence is required for trans-
location across the endoplasmic reticulum membrane, whereas
the prosequence functions as a high-affinity recognition site for
carboxylase [12,13]. After carboxylation, the protein is trans-
ported through the cell to the trans-Golgi network. There the
propeptide is cleaved from the protein by an as yet unknown
proconvertase, after which the fully modified, mature Gla-protein
is secreted into the circulation [14]. Therefore circulating mature
Gla-proteins lack the propeptide domain. By using carboxylating
Abbreviations used: bEELOMe, tripeptide t-butoxycarbonyl-Glu-Glu-Leu-OMe; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-
propanesulphonic acid ; d-OC, descarboxy-osteocalcin ; d-OC13–25 and d-OC22–31, synthetic descarboxy-osteocalcin residues 13–25 and 22–31
respectively ; FLAG, Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys ; Fmoc, fluoren-9-ylmethoxycarbonyl ; Gla, γ-carboxyglutamate ; HPC4, Glu-Asp-Gln-Val-Asp-
Pro-Arg-Leu-Ile-Asp-Gly-Lys ; KH2, vitamin K hydroquinone; MGP, matrix Gla-protein ; OC, osteocalcin ; OC
1–16, OC13–25, OC22–31 and OC29–43, synthetic
osteocalcin residues 1–16, 13–25, 22–31 and 29–43 respectively ; ProFIX and ProOC, synthetic propeptides (®18 to ®1) of human factor IX and human
osteocalcin respectively ; Pro(Glu)10, synthetic human prothrombin propeptide covalently attached to 10 Glu residues ; ProIX-59 Q/S, 59 amino acid
peptide containing the human factor IX propeptide and the first 41 residues of factor IX γ-carboxyglutamate domain (sequence ®18 to 41) with an
Arg!Gln mutation at the ®4 position and an Arg!Ser mutation at position ®1; ProPT-28 F/A, synthetic peptide consisting of residues ®18 to ­10
of human descarboxy-prothrombin with a Phe!Ala mutation at position ®16.
1 To whom correspondence should be addressed (e-mail b.soute!bioch.unimaas.nl).
76 µM. In contrast with the other vitamin K-dependent proteins,
free propeptides do not inhibit descarboxy-osteocalcin carboxyl-
ation.Moreover, propeptide-containing substrates were inhibited
neither by osteocalcin nor by its propeptide. From our studies we
conclude that descarboxy-osteocalcin must have an internal
recognition sequence that binds to γ-glutamylcarboxylase at a
site different from the propeptide-recognition site.
Key words: bone Gla-protein, γ-carboxyglutamate, phyllo-
quinone, post-translational processing.
systems in itro it was shown that small synthetic peptides
lacking the propeptide [e.g. the pentapeptide Phe-Leu-Glu-Glu-
Leu (FLEEL)] are poor substrates with K
m
values in the
millimolar range [15,16]. Under similar conditions, K
m
values for
peptides that did contain the prosequence of either prothrombin
or factor IX were three or four orders of magnitude lower [17].
In addition, the binding of prosequence-containing substrates
led to a 90–95% decrease in K
m
for the cofactor vitamin K
hydroquinone, suggesting an allosteric effect of the prodomain
on binding to carboxylase [18]. Remarkably, the addition of free
propeptide did not affect the K
m
for vitamin K hydroquinone,
and resulted in only a minor decrease (less than 90%) in the K
m
for small peptide substrates [19].
During recent years it has been shown that heat-decarboxylated
bovine OC can serve as a substrate for bovine liver carboxylase
[11,20]. The protein is exceptional because, despite its lack of a
prodomain, reported K
m
values are comparable with those of
prodomain-containing substrates [21,22]. Because heat-de-
carboxylation can cause unwanted and undefined damage to the
protein molecule, we have prepared synthetic human OC, in both
its carboxylated and non-carboxylated (descarboxy) forms; the
preparations are designated here as OC and d-OC respectively.
In the present study we compared the substrate properties of d-
OC with those of other well-known substrates for carboxylase
and we tested the extent to which OC is capable of inhibiting the
carboxylation of various substrates. Finally we investigated
whether the low K
m
values for d-OC are the result of an
unusually high affinity of its Gla motif for the carboxylase active
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site or, alternatively, of an internal docking sequence located
elsewhere in the molecule.
MATERIALS AND METHODS
Reagents
All chemicals were of analytical grade or higher. Vitamin K
"
(Konakion2, mixed micelles) was purchased from Hoffmann-La
Roche (Basel, Switzerland), NaH"%CO
$
with a specific radio-
activity of 50 mCi}mmol was from New England Nuclear
(Boston, MA, U.S.A.) and 3-[(3-cholamidopropyl)dimethyl-
ammonio]-2-hydroxy-1-propanesulphonic acid (CHAPS) was
from Sigma (St. Louis, MO, U.S.A.). The insect cell expression
vector (pVL1392) was purchased from PharMingen (San Diego,
CA, U.S.A.) and the baculovirus viral DNA (BacVector 3000)
was purchased from Novagen (Madison, WI, U.S.A.). The Sf9
(Spodoptera frugiperda) cells were obtained from the Lineburger
Cancer Center at the University of North Carolina–Chapel Hill,
and the High Five (Trichoplusia ni) cells were a gift from Dr.
Thomas Kost (Glaxo-Wellcome, Research Triangle Park, NC,
U.S.A.). Affinity resin with a Glu-Asp-Gln-Val-Asp-Pro-Arg-
Leu-Ile-Asp-Gly-Lys (HPC4) antibody tag was provided by Dr.
Charles T. Esmon (Oklahoma Medical Research Foundation,
Oklahoma City, OK, U.S.A.). The Asp-Tyr-Lys-Asp-Asp-Asp-
Asp-Lys (FLAG) antibody epitope and the FLAG peptide
standards were purchased from Sigma.
Peptides
Synthetic OC residues 1–16, 13–25, 22–31 and 29–43 (OC"–"',
OC"$–#&, OC##–$", OC#*–%$ respectively), synthetic descarboxy-
osteocalcin (d-OC) residues 13–25 and 22–31 (d-OC"$–#& and d-
OC##–$" respectively) and synthetic propeptides (®18 to ®1) of
human factor IX and human OC (ProFIX and ProOC respectively)
were synthesized by Pepscan Systems (Lelystad, The Nether-
lands). Both Phe-Leu-Glu-Glu-Leu (FLEEL) and t-butoxy-
carbonyl-Glu-Glu-Leu-OMe (bEELOMe) were purchased from
Table 1 Sequences of various peptide substrates and inhibitors
Abbreviations used: ProlX-59 Q/S, the propeptide and Gla-domain of human descarboxyfactor IX, in which R–4 has been replaced by Q, and R–1 has been replaced by S; Pro(Glu)
10
, the
prosequence of human prothrombin covalently bound to ten Glu residues; proPT28 F/A, the prosequence of human descarboxyprothrombin with the first 10 residues of the Gla-domain, in
which F–16 has been replaced by A;   stands for gammacarboxyglutamate.
Bachem (Bubendorf, Switzerland). A recombinant 59-residue
peptide containing the human factor IX propeptide and the first
41 residues of factor IX γ-carboxyglutamate domain (sequence
®18 to 41) with an Arg!Gln mutation at the ®4 position and
an Arg!Ser mutation at position ®1 (ProIX-59 Q}S) was
produced and purified as described previously [17]. Synthetic
human prothrombin propeptide covalently attached to 10 Glu
residues [Pro(Glu)
"!
] and a synthetic peptide consisting of residues
®18 to ­10 of human descarboxy-prothrombin with a Phe!
Ala mutation at position ®16 (ProPT-28 F}A) were synthesized
by Perkin Elmer (Nieuwerkerk aan de IJssel, The Netherlands).
The amino acid sequences of the various peptides are listed in
Table 1.
Synthesis of OC and d-OC
Mature 49-residue OC and d-OC (Table 1) were synthesized by
solid-phase peptide synthesis by using amino acids with fluoren-
9-ylmethoxycarbonyl (Fmoc)-protected α-amino groups on a
431A peptide synthesizer (PerkinElmer, Foster City, CA, U.S.A.)
with standard FastMoc programmes. The side-chain-protecting
groups used were: trityl for Asn, Cys, Gln and His; t-butyl for
Tyr; 2,2,5,7,8-pentamethyl-chroman-6-sulphonyl for Arg; and t-
butyl ester for Asp, Gla and Glu. All reagents and amino acids,
except for the protected amino acid Gla (Bachem), were peptide-
synthesis grade from Perkin Elmer. After each coupling step, the
free N-termini of non-reacted peptides were capped by acetic
anhydride to avoid the elongation of incompletely synthesized
peptides. To cleave the peptide from the resin and to remove the
side-chain-protecting groups, the resin-bound protein was stirred
for 90 min at room temperature in a cleavage mixture containing
0.75 g of crystalline phenol, 250 µl of ethanedithiol, 500 µl of
thioanisole, 500 µl of doubly distilled water and 10 ml of tri-
fluoroacetic acid. The peptide was separated from the resin by
filtration through a medium-porosity glass filter and precipitated
in cold methyl t-butyl ether. The peptide was washed with methyl
t-butyl ether, dissolved in water and dried. The amino acid
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sequence of the synthetic proteins was confirmed by Edman
degradation on a 477A}120A protein sequencer (Perkin Elmer).
MS of OC and d-OC
To verify the purity and the full carboxylation at positions 17, 21
and 24 of the synthetic OC and the purity of d-OC, electrospray
ionization MS was performed on a Micromass Platform II
(Micromass UK Ltd., Altrincham, Cheshire, U.K.) single-
quadrupole benchtop mass spectrometer operating in positive
ionizationmode.For theMS full-scan spectra, datawere acquired
in continuum mode over the range m}z 600–3000 in 2 s at unit
mass resolution. A cone voltage of 35 V was set, which produces
predominantly MH+ ions with little evidence of fragmentation
for this type of peptide. Instrumental control, data acquisition
and data processing were performed with the MASSLYNX
software package (version 2.3). The observed average m}z of OC
of 5930.85 units was compared with the calculated MH+ average
mass of 5931.55 units. Also the observed average m}z of d-OC of
5800.05 units was compared with its calculated MH+ average
mass of 5799.45 units. The calculated masses of both OC and d-
OC (with a free N-terminus and a carboxy group at the C-
terminus) did not differ significantly from the measured masses
and we therefore conclude (1) that the OC was pure and fully
carboxylated and (2) that d-OC was pure and not fragmented.
Expression of recombinant human carboxylase in Trichoplusia ni
High Five cells
The cDNA encoding the human vitamin K-dependent car-
boxylase was sub-cloned into the EcoRI site of the pVL1392
vector. The sequence coding for the FLAG antibody epitope was
introduced at the N-terminal end of the carboxylase and an
HPC4 antibody tag (Glu-Asp-Gln-Val-Asp-Pro-Arg-Leu-Ile-
Asp-Gly-Lys) [23] was added at the C-terminal end. The
engineered vector was co-transfected with baculovirus BacVector
3000 triple-cut virus DNA into Sf9 (Spodoptera frugiperda) cells.
Recombinant virus was isolated by plaque purification, amplified
and titred by plaque assay in accordance with the manufacturer’s
instructions (PharMingen). The expression of carboxylase was
done by infection of approx. 2¬10'}ml High Five cells with the
recombinant virus at a multiplicity of infection of approx. 1.
Cells were collected after 48 h by centrifugation, then stored at
®80 °C.
Preparation of microsomes from High Five cells
A total of 5¬10) cells expressing the recombinant human
carboxylase were washed with buffer A [25 mM Tris}HCl (pH
7.4)}150 mM NaCl] and a protease inhibitor cocktail [24] consist-
ing of EDTA (2 mM), dithiothreitol (2 mM), Phe-Pro-Arg-
chloromethane (0.125 µg}ml), Phe-Phe-Arg-chloromethane
(0.125 µg}ml), leupeptin (0.5 µg}ml), pepstatin (0.7 µg}ml),
PMSF (34 µg}ml) and aprotinin (2 µg}ml) together with 10%
(v}v) glycerol and resuspended in 50 ml of buffer A. The sample
was homogenized by five strokes with a Dounce homogenizer
and then sonicated with twenty 5 s pulses and an interval time of
25 s with an Ultrasonic Heat Systems sonicator. Cellular debris
was removed by centrifugation at 4000 g for 15 min. The
supernatant was then centrifuged at 105000 g for 1 h. The
microsomal pellet was resuspended in buffer A with a final
protein concentration of 20 mg}ml, 1¬protease inhibitor cock-
tail and 10% (v}v) glycerol, aliquotted and stored at ®80 °C
until further use.
Purification of recombinant human carboxylase with HPC4
antibody resin
Microsomes were diluted to a final protein concentration of
12 mg}ml and solubilized by the addition of an equal volume of
solubilization buffer [50 mM Tris}HCl (pH 7.4)}0.15 M NaCl}
1% (v}v) CHAPS}0.2% phosphatidylcholine}10% (v}v)
glycerol}1¬protease inhibitor cocktail] at 4 °C for 1 h. The
solubilized microsomes were centrifuged at 105000 g for 1 h and
the pellet was discarded. A total of 10 ml of HPC4 resin was
equilibrated with wash buffer [20 mM Tris}HCl (pH 7.4)}
150 mM NaCl}0.5% CHAPS}0.2% phosphatidylcholine}
1¬protease inhibitor cocktail] and added to the solubilization
supernatant along with a final concentration of 5 mM CaCl
#
,
then incubated overnight with gentle stirring. The resin was
centrifuged and poured into a column, washed with 50 ml of
wash buffer plus 5 mM CaCl
#
and eluted with wash buffer plus
10 mM EDTA. Carboxylase samples were collected, aliquotted
and stored at ®80 °C. Enzyme concentration was estimated
from dot-blots of carboxylase by using the FLAG antibody and
known concentrations of FLAG antibody standard.
Carboxylase assay
Standard reaction mixtures (125 µl) contained: 6 nmol of HPC4-
purified γ-glutamylcarboxylase, 25 mM Tris}HCl, pH 7.4,
150 mM NaCl, 0.2% (v}v) CHAPS, 0.2% phosphatidylcholine,
5 µCi of NaH"%CO
$
, 222 µM vitamin K hydroquinone (KH
#
)
and 5 mM dithiothreitol. Substrates were added as indicated.
The mixture was incubated at 20 °C for 30 min in sealed tubes.
Kinetic analysis was performed on samples drawn at 0, 15 and
30 min. All reactions were stopped by the addition of 0.8 ml of
5% (w}v) trichloroacetic acid to 100 µl of reaction mixture;
unbound "%CO
#
was removed by boiling for 3 min. After cooling
of the mixture, 5 ml of Formula 989 (Packard Bioscience,
Groningen, The Netherlands) was added. Finally samples were
counted with a Wallac (Turku, Finland) 1414 WinSpectral liquid-




Kinetic constants for d-OC carboxylation
Whereas bovine liver microsomal carboxylase can be contami-
nated with propeptide-containing endogenous substrates, the
affinity-purified enzyme is saturated with free propeptide as a
consequence of its elution from the affinity ligand. Neither of
these systems is suitable for determining the kinetic constants for
OC carboxylation or the effects thereon of various propeptides.
Therefore we used purified recombinant human carboxylase
expressed in insect cells known to be free of endogenous precursor
proteins. Carboxylase was eluted from the affinity column in the
absence of free propeptide, thereby generating carboxylase
completely devoid of interfering propeptide-containing proteins.
Using this system we have demonstrated for the first time that,
in the absence of propeptide, d-OC is a good substrate for
carboxylase. Kinetic constants of various OC-derived substrates
were compared with other well-known substrates for carboxylase
(Table 2). Substrates containing a propeptide sequence were
characterized by K
m
values between 0.4 and 5 µM, whereas the
K
m
s for propeptide-deficient peptides were in the millimolar
range. d-OC, which lacks an N-terminal propeptide, is an
exception in this respect with a K
m
of 1.7 µM. Remarkably, the
corresponding peptide, d-OC"$–#&, was a poor substrate for
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Table 2 Kinetic constants for different peptide substrates and the cofactor
KH2 during carboxylation
Reactions were performed as detailed in the Materials and methods section. Kinetic parameters
were determined by fitting the data to the Michaelis–Menten equation. Values are means³S.D.






ProIX-59 Q/S 0.51³0.09 90³13 5³0.5
ProPT-28 F/A 5.35³0.77 183³18 3³0.4
Pro(Glu)10 0.56³0.18 119³15 9³1.1
d-OC 1.71³0.35 287³17 13³0.9
d-OC13−25 9100³2050 470³57 61³3.4
bEELOMe 2000³100 182³11 39³2.3
FLEEL 2400³200 401³32 34³1.7
carboxylase with a K
m
three orders of magnitude higher than
that for d-OC, similar to short peptide substrates such as FLEEL.
These experiments demonstrate that d-OC contains an internal
recognition site for carboxylase, permitting its efficient carboxyl-
ation. Because this recognition site was not present in d-OC"$–#&
(containing the entire OC Gla motif) it seems that a sequence
outside its Gla motif contributes to the recognition of mature OC
by carboxylase. We have also tested d-OC##–$" for its ability to
serve as a substrate for carboxylase. However, this peptide was
not measurably carboxylated, nor was carboxylation observed
when OC"–"' was added (results not shown). It has been shown





is relatively high but that it is substantially
decreased on binding of propeptide-containing substrates [18].
The data in Table 2 show that in this respect d-OC only partly




that is approx. 3-fold that for the carboxylation of ProIX-59
Q}S, but almost 80% lower than that for the carboxylation of d-
OC"$–#&. These results demonstrate that the presence of the
prosequence is not an absolute requirement for increasing the
affinity between carboxylase and its cofactor KH
#
. The possibility
cannot yet be excluded that the function of the prosequence in
OC precursors is to induce a more pronounced interaction
between carboxylase and KH
#




to the same values as those observed for the other propeptide-
containing substrates. It has been shown previously that the
prosequence in propeptide-containing substrates possesses the





[18] ; this might contribute to a more efficient utilization of KH
#
in the carboxylation of OC. An explanation for this phenomenon
might be found in postulating an allosteric conformational
change of carboxylase on binding of the prosequence. Definite
proof of this hypothesis might be obtained from a prosequence-
containing OC molecule. However, high-efficiency long-chain
synthesis by Fmoc chemistry is limited to approx. 50 residues in
our hands. Only a few successful long-chain syntheses have been
reported so far with the linear Fmoc protocol [25–28], indicating
the problems accompanying the synthesis of these long peptide
chains (more than 50 residues).
Inhibitory effect of OC on d-OC and bEELOMe carboxylation
Because of the high degree of sequence similarity of d-OC and
OC, it seemed feasible that both molecules might have an affinity
for carboxylase. In that case OC would be expected to act as an
inhibitor of d-OC carboxylation. We therefore investigated the
Figure 1 Effect of OC on the carboxylation of different substrates
All incubations were at 20 °C for 30 min. All values are means for at least three independent
measurements, and are expressed as a percentage (³S.D.) of the non-inhibited reaction rate.
Symbols : *, carboxylation of 2 µM d-OC ; E, carboxylation of 1 µM of ProIX-59 Q/S ; ^,
carboxylation of 5 mM bEELOMe at increasing concentrations of OC. If error bars are not visible
they were smaller than the symbol used.
Table 3 Effect of propeptides on apparent Km for various substrates in the
vitamin K-dependent carboxylation reaction
Reactions were performed as detailed in the Materials and methods section. Kinetic parameters
were determined by fitting the data to the Michaelis–Menten equation. Values are means³S.D.
for at least three independent determinations.
Km (µM)
With 20 µM With 20 µM
Substrate No addition ProFIX ProOC
d-OC 1.7³0.35 1.9³0.24 1.8³0.37
d-OC13−25 9100³2050 4000³900 10000³1900
ProIX-59 Q/S 0.5³0.10 2.6³0.35 0.4³0.26
bEELOMe 2100³100 600³400 2200³800
potential inhibitory effect of OC on the carboxylation of various
substrates. As is shown in Figure 1, the carboxylation of the
propeptide-containing ProIX-59 Q}S (1 µM) was not inhibited,
even at a 200-fold molar excess of OC. The carboxylation of d-
OC was inhibited with a K
i
of 76 µM (approx. 45-fold the K
m
for
d-OC), and bEELOMe with a K
i
of 104 µM (approx. 0.05-fold
the K
m
for bEELOMe). These results show that OC is not an
inhibitor for propeptide-containing substrates, whereas it inhibits
propeptide-deficient substrates with high and low sequence
similarities to similar extents, suggesting that elements of rec-
ognition are shared by both substrate and product. In an attempt
to locate more precisely the sequence responsible for the high
affinity of d-OC for carboxylase, we tested the potential inhibitory
effects of a number of peptides derived from OC: OC"–"', OC"$–#&,
OC##–$" and OC#*–%$. However, none of these peptides, whether
alone or in combination, inhibited the carboxylation of d-OC.
Effect of free propeptides on carboxylation of d-OC and ProIX-59
Q/S
As has previously been shown [29], the presence of free propeptide
stimulates substrate carboxylation in itro by lowering the K
m
for
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Figure 2 Effect of propeptides on substrate carboxylation
The carboxylation of 1 µM ProIX-59 Q/S was measured at various concentrations of either
ProFIX (E) or ProOC (D) ; the carboxylation of 2 µM of d-OC was measured at various
concentrations of either ProFIX (+) or ProOC (*). Incubations were performed at 20 °C for
30 min. All values are means for at least three independent measurements, and are expressed
as a percentage (³S.D.) of the non-inhibited reaction rate. If error bars are not visible they
were smaller than the symbol used.
substrates derived from blood-clotting factors. In the present
study we investigated whether propeptides have a similar effect
on substrates derived from OC. In addition, we examined to
what extent free propeptides might act as competitive inhibitors
for propeptide-containing substrates during substrate recognition
by carboxylase. The propeptides used for these studies were
ProFIX and ProOC ; we measured the effects of these propeptides
on the carboxylation of four different substrates. The data shown
in Table 3 were obtained in the presence of either 20 µM ProFIX
or 20 µM ProOC and demonstrate that ProFIX acted as an inhibitor
for the propeptide-containing ProIX-59 Q}S, and that it mildly
stimulated the propeptide-deficient bEELOMe. Its effects on
OC-derived substrates were negligible. In contrast, ProOC did not
affect the carboxylation of either substrate. At increasing concen-
trations of ProFIX, a dose-dependent inhibition with a K
i
of
0.8 µM of ProIX-59 Q}S was observed (Figure 2), whereas even
at 200 µM of ProFIX the carboxylation of d-OC remained
unaffected. In contrast, ProOC did not inhibit either substrate
even at very high concentrations. The fact that ProOC did not
inhibit ProIX-59 Q}S carboxylation is consistent with its reported
low affinity for carboxylase (T. Stanley, D. Jin, P.-J. Lin and
D. W. Stafford, unpublished work). From these results we con-
clude (1) that the affinity of carboxylase for ProOC must be
substantially lower than that for ProFIX, and (2) that carboxylase
must have at least two different docking sites : a high-affinity site
for d-OC and a site for propeptide-containing substrates. In our
opinion it is unlikely that an attached propeptide lowers the K
m
for OC even further. Results reported by Benton et al. [20]
showed only a 3-fold difference between propeptide-lacking and
propeptide-containing d-OC (0.72 µM compared with 0.24 µM
respectively). Comparison of these results with ours is hampered
by the fact that Benton et al. studied the kinetic parameters in
purified bovine carboxylase that contained 100 µM free human
factor X propeptide. OC itself might contain an internal recog-
nition site for carboxylase. This is also seen in MGP, another
Gla-protein synthesized in bone. Because OC and MGP have
Received 5 February 1999/12 April 1999 ; accepted 5 May 1999
significant sequence similarities, it has been suggested that both
proteins have developed from a common ancestor protein [30,31].
However, no sequence homology between the internal propeptide
of MGP and mature OC is seen; we therefore suggest the
presence of a different binding site on carboxylase.
In conclusion, we have been able to demonstrate that d-OC
binds with high affinity to carboxylase, and that the OC
prosequence does not have a noticeable role in the enzyme–
substrate interaction. Moreover, the results strongly suggest the
presence of two substrate-docking sites on carboxylase : one
recognizing the prosequence in clotting-factor-type substrates,
and another with high affinity for OC precursors. However, it is
still not known which structural determinants of OC contribute
to its recognition by carboxylase.
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